Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.S. Suh
Pcn144 - Cost-Effectiveness of Cabozantinib for Patients With Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs54 - Cost-Effectiveness Analysis of Reslizumab for Patients With Severe Eosinophilic Asthma Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting B2-Agonists in South Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcn94 - Cost-Effectiveness of Cabozantinib Versus Sunitinib or Pazopanib as First-Line Treatment of Patients With Advanced Renal Cell Carcinoma in the Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Brain Complete Response to Cabozantinib Prior to Radiation Therapy in Metastatic Renal Cell Carcinoma
Case Reports in Urology
Cost Effectiveness of Regorafenib as Second-Line Therapy for Patients With Advanced Hepatocellular Carcinoma
Cancer
Cancer Research
Oncology
Cabozantinib in Combination With Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Molecular Cancer Therapeutics
Cancer Research
Oncology
Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma in Adults Following Prior Vascular Endothelial Growth Factor Targeted Therapy: Clinical Trial Evidence and Experience
Therapeutic Advances in Urology
Urology
Spotlight on Cabozantinib for Previously Untreated Advanced Renal Cell Carcinoma: Evidence to Date
Cancer Management and Research
Oncology
Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Pcn185 - Cost-Effectiveness of Nivolumab in Second-Line Treatment of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
